Calcitonin doubling time in medullary thyroid carcinoma after the detection of distant metastases keenly predicts patients’ carcinoma death
Author:
Affiliation:
1. Department of Surgery, Kuma Hospital, Kobe, Japan
2. Department of Internal Medicine, Kuma Hospital, Kobe, Japan
Publisher
Japan Endocrine Society
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Link
https://www.jstage.jst.go.jp/article/endocrj/63/7/63_EJ16-0140/_pdf
Reference5 articles.
1. 1. Ito Y, Miyauchi A, Yabuta T, Fukushiim M, Inoue H, et al. (2009) Alternative surgical strategies and favorable outcomes in patients with medullary thyroid carcinoma in Japan: experience of a single institution. World J Surg 33: 58-66.
2. 2. Miyauchi A, Onishi T, Morimoto S, Takai S, Matsuzuka F, et al. (1984) Re-lation of doubling time of plasma calcitonin levels to prognosis and recurrence of me-dullary thyroid carcinoma. Ann Surg 199: 461-466.
3. 3. Barbet J, Campion L, Kraeber-Bodere F, Chatal JF, GTE Study Group (2005) Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-time in patients with medullary thyroid carcinoma. J Clin Endocrinol Metab 90: 6077-6084.
4. 4. Wells SA Jr, Robinson BR, Gagel RF, Dralle H, Fagin JA, et al. (2012) Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial. J Clin Oncol 30: 134-141.
5. 5. Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, et al. (2015) Revised American Thyroid Association Guidelines for the management of medullary thyroid carcinoma. Thyroid 25: 567-610.
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Disease-free survival and the prognostic factors affecting disease-free survival in patients with medullary thyroid carcinoma: a multicenter cohort study;Endocrine;2024-04-03
2. Medullary Thyroid Cancer: Updates and Challenges;Endocrine Reviews;2023-05-19
3. Update on C-Cell Neuroendocrine Neoplasm: Prognostic and Predictive Histopathologic and Molecular Features of Medullary Thyroid Carcinoma;Endocrine Pathology;2023-03
4. Neoplasms of the Thyroid;Holland‐Frei Cancer Medicine;2022-10-21
5. Prospective study on the clinical relevance of 18F-DOPA positron emission tomography/computed tomography in patients with medullary thyroid carcinoma;Endocrine;2022-04-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3